How have CWBR shares performed in 2024?

CohBar's stock was trading at $0.74 at the start of the year. Since then, CWBR shares have increased by 21.7% and is now trading at $0.9003. View the best growth stocks for 2024 here .

When is CohBar's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our CWBR earnings forecast .

How were CohBar's earnings last quarter?

CohBar, Inc. (NASDAQ:CWBR) announced its earnings results on Monday, November, 15th. The company reported ($1.50) earnings per share for the quarter, topping analysts' consensus estimates of ($2.70) by $1.20. During the same quarter in the prior year, the firm posted ($1.20) earnings per share.

When did CohBar's stock split?

CohBar's stock reverse split before market open on Friday, September 23rd 2022. The 1-30 reverse split was announced on Friday, September 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of CohBar own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CohBar investors own include Strongbridge Biopharma (SBBP) , ZIOPHARM Oncology (ZIOP) , AcelRx Pharmaceuticals (ACRX) , Aptinyx (APTX) , Axcella Health (AXLA) , Aytu BioPharma (AYTU) , Calithera Biosciences (CALA) , Cidara Therapeutics (CDTX) , Catalyst Pharmaceuticals (CPRX) and DURECT (DRRX) .

Who are CohBar's major shareholders?

CohBar's stock is owned by a number of retail and institutional investors. Top institutional investors include RVW Wealth LLC (6.24%). Insiders that own company stock include Joseph J Sarret , Kenneth C Cundy and Misha Petkevich . View institutional ownership trends .

How do I buy shares of CohBar?

Shares of CWBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CWBR

CohBar (CWBR) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free CWBR Stock Alerts

$0.90

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.90
▼
$0.90
50-Day Range: $0.76
▼
$1.00
52-Week Range: $0.58
▼
$6.90

Volume: 215 shs
Average Volume: 1,523 shs
Market Capitalization: $2.62 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get CohBar alerts:

Ad DTI

Start loving Mondays like this

Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!

Weekend after weekend!

About CohBar Stock (NASDAQ:CWBR)

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

CWBR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CWBR Stock News Headlines

April 18, 2024 | americanbankingnews.com

CohBar (NASDAQ:CWBR) Stock Price Up 12.5%

April 16, 2024 | finance.yahoo.com

CohBar, Inc. (CWBR)

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

January 23, 2024 | morningstar.com

North American Morning Briefing: Stock Futures Steady as Earnings Season Ramps Up

January 19, 2024 | morningstar.com

CohBar Inc CWBR

January 9, 2024 | morningstar.com

North American Morning Briefing: Samsung Warning Knocks Tech Stocks

November 29, 2023 | benzinga.com

CohBar Stock (NASDAQ:CWBR) Dividends: History, Yield and Dates

November 28, 2023 | msn.com

CohBar announces Nasdaq's notice of delisting; does not plan to request hearing

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

November 1, 2023 | msn.com

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.67%

November 1, 2023 | benzinga.com

Why CohBar (CWBR) Stock Is Down Nearly 50% Today

August 15, 2023 | finanznachrichten.de

CohBar, Inc.: CohBar Reports Second Quarter 2023 Financial Results

August 14, 2023 | finance.yahoo.com

CohBar Reports Second Quarter 2023 Financial Results

July 17, 2023 | markets.businessinsider.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WTT, CWBR, DM

June 29, 2023 | markets.businessinsider.com

IMPORTANT ALERT: Halper Sadeh LLC Investigates PDCE, CWBR, EMAN, HMPT

June 5, 2023 | msn.com

CohBar's Acquisition Partner Touts Encouraging Data From Personalized Cancer Vaccine

June 3, 2023 | benzinga.com

Lifshitz Law PLLC Announces Investigations of CWBR, GHL, PDCE, and VECT

May 31, 2023 | benzinga.com

COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR

May 30, 2023 | finance.yahoo.com

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

May 25, 2023 | benzinga.com

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CohBar, Inc. Merger

May 24, 2023 | benzinga.com

Shareholder Alert: Ademi LLP investigates whether CohBar, Inc. has obtained a Fair Price in its transaction with Morphogenesis, Inc.

May 24, 2023 | msn.com

Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

May 23, 2023 | msn.com

CohBar Almost Quadruples amid Morphogenesis Merger

May 23, 2023 | benzinga.com

CohBar Stock Doubles: Company Agrees To Merge With Morphogenesis To Advance Late-Stage Oncology Candidates

May 23, 2023 | investorplace.com

Why Is CohBar (CWBR) Stock Up 130% Today?

May 23, 2023 | marketwatch.com

Cohbar to Merge with Morphogenesis; Combined Company to Be Called TuHURA Biosciences

May 23, 2023 | technews.tmcnet.com

CWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to Shareholders

See More Headlines

Receive CWBR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CohBar and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:CWBR
CUSIP: N/A
CIK: 1522602
Web: www.cohbar.com
Phone: (650) 446-7888
Fax: N/A
Employees: 9
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.27 per share
Price / Book: 0.17

Miscellaneous

Outstanding Shares: 2,910,000
Free Float: 2,718,000
Market Cap: $2.62 million
Optionable: Not Optionable
Beta: 1.54

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Dr. Pinchas Cohen Dean (Age 67)
M.D., Founder & Member of Scientific Advisory Board
Comp: $65.25k
Dr. Nir Yacov Barzilai M.D. (Age 68)
Founder & Member of Scientific Advisory Board
Comp: $65.25k
Dr. John M. Amatruda M.D. (Age 78)
Ph.D., Co-Founder
Comp: $31.5k
Ms. Jordyn Tarazi
Director of Investor Relations

Key Competitors

View All Competitors

Institutional Ownership

RVW Wealth LLC
Sold 5,263,213 shares on 4/8/2024
Ownership: 6.237%

View All Institutional Transactions

CWBR Stock Analysis - Frequently Asked Questions

How have CWBR shares performed in 2024?: CohBar's stock was trading at $0.74 at the start of the year. Since then, CWBR shares have increased by 21.7% and is now trading at $0.9003.
View the best growth stocks for 2024 here.
When is CohBar's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our CWBR earnings forecast.
How were CohBar's earnings last quarter?: CohBar, Inc. (NASDAQ:CWBR) announced its earnings results on Monday, November, 15th. The company reported ($1.50) earnings per share for the quarter, topping analysts' consensus estimates of ($2.70) by $1.20. During the same quarter in the prior year, the firm posted ($1.20) earnings per share.
When did CohBar's stock split?: CohBar's stock reverse split before market open on Friday, September 23rd 2022. The 1-30 reverse split was announced on Friday, September 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of CohBar own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CohBar investors own include Strongbridge Biopharma (SBBP), ZIOPHARM Oncology (ZIOP), AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX) and DURECT (DRRX).
Who are CohBar's major shareholders?: CohBar's stock is owned by a number of retail and institutional investors. Top institutional investors include RVW Wealth LLC (6.24%). Insiders that own company stock include Joseph J Sarret, Kenneth C Cundy and Misha Petkevich.
View institutional ownership trends.
How do I buy shares of CohBar?: Shares of CWBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CWBR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial